Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on April 21, 2025
Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402
GlobeNewswire
·
April 21, 2025
Eric Venker, M.D. (currently President and COO of Roivant) appointed as CEO of Immunovant and Tiago Girao appointed as CFO of Immunovant Pete Salzmann, M.D. retired from his role as Immunovant CEO and Director Leadership change is part of a broader …
Cryptocurrency has quietly become the preferred asset reserve for investment, and KSD Miner is very popular among users around the world.
GlobeNewswire
·
April 21, 2025
London, UK, April 21, 2025 (GLOBE NEWSWIRE) -- From Change to Big Cash: How to Make $1 Million with $100 in 2025 As times have changed, Will the US tariffs lead to a depreciation of the US dollar? Cryptocurrency has quietly become the preferred asset …
Elixir AI Blazes into Web3 — Achieves 10x Growth on Launch Day
GlobeNewswire
·
April 21, 2025
New York, NY, April 21, 2025 (GLOBE NEWSWIRE) -- In just 24 hours, Elixir AI made waves across the crypto world. Officially launched on April 19, the AI-powered 3D content generation platform saw its native token $ELXAI skyrocket by 10x, signaling early …
Castellum, Inc. Reduces Principal Balance by $2 Million on Notes Payable to Robert Eisiminger and Extends Maturity Date
GlobeNewswire
·
April 21, 2025
VIENNA, Va., April 21, 2025 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM) ("Castellum" or "CTM"), a cybersecurity, electronic warfare, and software engineering services company focused on the federal government, announces that it has entered …
Affimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement
GlobeNewswire
·
April 21, 2025
MANNHEIM, Germany, April 21, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it has received a written notice (the “ …
Alumis and ACELYRIN Announce Amended Merger Agreement
GlobeNewswire
·
April 21, 2025
ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRIN stockholders to now own approximately 52% and 48%, respectively, of the combined company on a fully diluted basis Merger …
Alumis and ACELYRIN Announce Amended Merger Agreement
GlobeNewswire
·
April 21, 2025
ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRIN stockholders to now own approximately 52% and 48%, respectively, of the combined company on a fully diluted basis Merger …
Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis
GlobeNewswire
·
April 21, 2025
Independent Cost-Effectiveness Analysis Concludes Nociscan is Effective and Less Costly Compared to Provocative Discography Conclusions Illustrate Nociscan Saves $1,712 per Patient and Improves Surgical Success by 10% BROOMFIELD, Colo., April 21, 2025 ( …
Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development
GlobeNewswire
·
April 21, 2025
VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to- …